February 27, 2020
Spaulding Clinical Research Awarded Five-Year Contract With FDA
WEST BEND, Wis.–(BUSINESS WIRE)–Spaulding Clinical Research today announced that it has been awarded a five-year contract with the U.S. Food…
Pharmaceuticals, Biotechnology and Life Sciences
WEST BEND, Wis.–(BUSINESS WIRE)–Spaulding Clinical Research today announced that it has been awarded a five-year contract with the U.S. Food…
13 Inaugural Directors Bring Wide-Ranging Experience, Expertise and a Focus on Driving Shareholder Value HERTFORDSHIRE, England, PITTSBURGH & NEW YORK–(BUSINESS…
SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces an update to its financial outlook and raises its 2020 financial guidance.…
ANN ARBOR, Mich.–(BUSINESS WIRE)–$KBLB #KBLB–Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”), the leading developer of spider silk based fibers,…
ANN ARBOR, Mich.–(BUSINESS WIRE)–$KBLB #KBLB–Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”), the leading developer of spider silk based fibers,…
CTP-543 Phase 3 Program for Treatment of Alopecia Areata Expected to Begin in 2020 New CTP-543 Patent Covers Pharmaceutical Compositions…
– Conference Call and Webcast Today, February 27, 2020, at 8:00 a.m. ET – NEW YORK–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq:…
– Conference Call and Webcast Today, February 27, 2020, at 8:00 a.m. ET – NEW YORK–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq:…
Enrollment ongoing in Phase 3 clinical trial of zilucoplan in gMG, with top-line results expected in early 2021 First patient…
Enrollment ongoing in Phase 3 clinical trial of zilucoplan in gMG, with top-line results expected in early 2021 First patient…